Arcutis Biotherapeutics's top three insider shareholders as of April 17, 2026 are Life Sciences Viii, L.P. Frazier (TenPercentOwner, 8.76Mn shares), Bhaskar Chaudhuri (Director, 867.83K shares), Todd Watanabe (President And Ceo, 785.96K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Life Sciences Viii, L.P. Frazier | - | 8,764,232 | 0 | 26 Oct, 2023 |
| Bhaskar Chaudhuri | - | 867,826 | 0 | 16 Jun, 2025 |
| Todd Watanabe | President And Ceo | 785,957 | 0 | 03 Mar, 2026 |
| David W Osborne | Chief Technical Officer | 268,854 | 0 | 08 Mar, 2023 |
| David Joseph Topper | Chief Financial Officer | 182,774 | 0 | 03 Apr, 2025 |
| Larry Todd Edwards | Svp Chief Commercial Officer | 175,178 | 0 | 03 Mar, 2026 |
| Matthew Richard Moore | Svp And Chief Business Officer | 145,505 | 0 | 03 May, 2024 |
| Masaru Matsuda | See Remark | 136,932 | 0 | 03 Mar, 2026 |
| Latha Vairavan | Svp Chief Financial Officer | 87,754 | 0 | 03 Mar, 2026 |
| Patrick Burnett | - | 80,651 | 0 | 04 Feb, 2026 |
| Kenneth A. Lock | Chief Commercial Officer | 63,429 | 0 | 08 Mar, 2023 |
| Patricia A. Turney | Svp, Operations | 62,862 | 0 | 08 Mar, 2023 |
| Scott L Burrows | Chief Financial Officer | 59,115 | 0 | 08 Mar, 2023 |
| Howard G. Welgus | Chief Medical Officer | 39,744 | 0 | 03 Apr, 2026 |
| Sue-Jean Lin | - | 26,735 | 0 | 25 Nov, 2025 |
| Todd Franklin Watanabe | - | 0 | 25,410 | 12 Jun, 2025 |
| Neha Krishnamohan | - | 22,123 | 0 | 17 Nov, 2025 |
| Keith R Leonard | - | 22,123 | 0 | 04 Mar, 2026 |
| Terrie Curran | - | 17,748 | 0 | 16 Jun, 2025 |
| John W Smither | Chief Financial Officer | 11,365 | 0 | 15 Feb, 2024 |
| Joseph L Turner | - | 4,312 | 0 | 03 Jun, 2022 |
| Amit Munshi | - | 4,021 | 0 | 08 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Howard G. Welgus | Common Stock | D | 10,000 | $23.88 | 39,744 | D | S |
| 02 Mar, 2026 | Howard G. Welgus | Common Stock | D | 10,000 | $25.65 | 49,744 | D | S |
| 02 Mar, 2026 | Keith R Leonard | Common Stock | A | 27,052 | $8.63 | 49,175 | D | M |
| 02 Mar, 2026 | Keith R Leonard | Common Stock | A | 12,220 | $7.51 | 61,395 | D | M |
| 02 Mar, 2026 | Keith R Leonard | Common Stock | D | 39,272 | $25.39 | 22,123 | D | S |
| 02 Mar, 2026 | Keith R Leonard | Stock Option (right to buy) | D | 27,052 | $0.00 | 0 | D | M |
| 02 Mar, 2026 | Keith R Leonard | Stock Option (right to buy) | D | 12,220 | $0.00 | 0 | D | M |
| 27 Feb, 2026 | Latha Vairavan | Common Stock | A | 27,000 | $0.00 | 90,607 | D | A |
| 27 Feb, 2026 | Todd Watanabe | Common Stock | A | 102,000 | $0.00 | 823,306 | D | A |
| 27 Feb, 2026 | Masaru Matsuda | Common Stock | A | 37,000 | $0.00 | 147,003 | D | A |
| 27 Feb, 2026 | Larry Todd Edwards | Common Stock | A | 30,000 | $0.00 | 178,865 | D | A |
| 02 Mar, 2026 | Latha Vairavan | Common Stock | D | 2,772 | $25.16 | 87,835 | D | S |
| 27 Feb, 2026 | Masaru Matsuda | Common Stock | D | 3,325 | $27.95 | 143,678 | D | S |
| 02 Mar, 2026 | Larry Todd Edwards | Common Stock | D | 3,584 | $25.16 | 175,281 | D | S |
| 02 Mar, 2026 | Todd Watanabe | Common Stock | D | 36,281 | $25.16 | 787,025 | D | S |
| 02 Mar, 2026 | Larry Todd Edwards | Common Stock | D | 103 | $25.91 | 175,178 | D | S |
| 02 Mar, 2026 | Masaru Matsuda | Common Stock | D | 6,553 | $25.16 | 137,125 | D | S |
| 02 Mar, 2026 | Latha Vairavan | Common Stock | D | 81 | $25.91 | 87,754 | D | S |
| 02 Mar, 2026 | Todd Watanabe | Common Stock | D | 1,068 | $25.91 | 785,957 | D | S |
| 27 Feb, 2026 | Latha Vairavan | Stock Option (right to buy) | A | 70,000 | $0.00 | 70,000 | D | A |